About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
Therapeutic Advances in T-Cell Lymphoma in 2024
By
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Stefan Barta
By
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Stefan Barta
0 views
March 7, 2024
Comments
0
Login to view comments.
Click here to Login
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
Recommended
AUTOPLAY
ON
Related
Newest
27:47
Indy Hematology Review
Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…
Feat.
S. Smith
08:18
Insights from 2023 ASH Annual Meeting
Treatment Strategies for Hematocrit Control in PV
Feat.
A. Zhou
17:07
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Comparative Review of Toxicities and Their…
Feat.
M. Minnema
29:26
Massachusetts General Hospital Cancer Center
Practice-Changing Updates in DLBCL and HL
Feat.
J. Erika Haydu
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
17:21
Daniel Addison
Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…
09:27
ASH 2022 Conference Coverage
MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…
Feat.
M. McMullin
05:38
GRACE
Epcoritamab in NHL - Incidence and Management of CRS
Feat.
T. Phillips
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
06:51
Insights from 2023 ASH Annual Meeting
Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…
Feat.
D. Tremblay
40:38
UChicago Medicine
Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …
Feat.
G. Venkataraman,
A. Perry,
K. Cahill,
A. Akmatbekov,
L. Wu
26:58
Total Health
Update on Cellular Therapy in Lymphoma
Feat.
B. Randolph
23:03
MyCancerHaven
Basics of T-Cell Lymphoma: Diagnosis and Treatment
Feat.
R. Vij,
N. Mehta-Shah
22:38
Indy Hematology Review
Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…
Feat.
T. Phillips
16:34
Jennifer Amengual
Top 5 Lymphoma Abstracts From ASH
33:11
Total Health
Bispecific Antibodies and CAR T-Cells for NHL: Challenges and Opport…
Feat.
K. Komanduri
10:49
Monia Marchetti
Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
13:58
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Intrathecal Rituximab + Dex for Refractory Sanctu…
Feat.
M. Salamoon
42:09
University of Colorado Department of Medicine
Immunotherapy in Lymphomas: The Present and the Future
Feat.
M. Kamdar
